National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 (COVID-19) Pandemic in Australia.
作者信息
Sluggett Janet K, Dinh Yen H, Wesselingh Steven L, Inacio Maria C, Caughey Gillian E
机构信息
UniSA Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia.
Registry of Senior Australians, Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
出版信息
Clin Infect Dis. 2021 Dec 6;73(11):2150-2152. doi: 10.1093/cid/ciab241.
Abstract
摘要
相似文献
1
National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 (COVID-19) Pandemic in Australia.
Clin Infect Dis. 2021 Dec 6;73(11):2150-2152. doi: 10.1093/cid/ciab241.
2
Outpatient parenteral antibiotic therapy and follow-up during the COVID-19 pandemic.
JAAPA. 2021 Dec 1;34(12):1. doi: 10.1097/01.JAA.0000800608.04046.79.
3
Reductions in Antibiotic Prescribing in Australia During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: National Prescribing Data.
Clin Infect Dis. 2022 Aug 24;75(1):e1202-e1203. doi: 10.1093/cid/ciac277.
4
Providing community intravenous therapy during the COVID-19 pandemic.
Br J Nurs. 2021 Oct 28;30(19):S4-S12. doi: 10.12968/bjon.2021.30.19.S4.
5
Trends in US Outpatient Antibiotic Prescriptions During the Coronavirus Disease 2019 Pandemic.
Clin Infect Dis. 2021 Aug 2;73(3):e652-e660. doi: 10.1093/cid/ciaa1896.
6
Antibiotics and the quality indicators for outpatient antibiotic use in Slovakia.
Ceska Slov Farm. 2021 Winter;70(6):199-205.
7
Management of diabetes-related foot disease in the outpatient setting during the COVID-19 pandemic.
Intern Med J. 2021 Jul;51(7):1146-1150. doi: 10.1111/imj.15392.
8
Impact of the strategies implemented by an antimicrobial stewardship program on the antibiotic consumption in the coronavirus disease 2019 (COVID-19) pandemic.
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1292-1293. doi: 10.1017/ice.2021.237. Epub 2021 May 21.
9
Ethical outpatient dermatology care during the coronavirus (COVID-19) pandemic.
J Am Acad Dermatol. 2020 May;82(5):1272-1273. doi: 10.1016/j.jaad.2020.03.047. Epub 2020 Mar 26.
10
Tackling antibiotic resistance during the COVID-19 pandemic is a new challenge for paediatricians.
Acta Paediatr. 2021 Sep;110(9):2650-2651. doi: 10.1111/apa.15988. Epub 2021 Jun 24.
引用本文的文献
1
Combined impact of the COVID-19 pandemic and the number of comorbidities on community antibiotic utilisation rates: a population-based retrospective cohort study using linked health administrative data in Quebec, Canada.
BMJ Open. 2025 Aug 27;15(8):e096283. doi: 10.1136/bmjopen-2024-096283.
2
Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data.
Antimicrob Resist Infect Control. 2024 Jul 12;13(1):76. doi: 10.1186/s13756-024-01434-0.
3
An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic.
Antibiotics (Basel). 2023 Jan 9;12(1):126. doi: 10.3390/antibiotics12010126.
4
Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 Pandemic.
Antibiotics (Basel). 2022 May 11;11(5):643. doi: 10.3390/antibiotics11050643.
5
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020.
PLoS One. 2022 Feb 2;17(2):e0263437. doi: 10.1371/journal.pone.0263437. eCollection 2022.
6
COVID-19 and Antibiotic Prescribing in Pediatric Primary Care.
Pediatrics. 2022 Feb 1;149(2). doi: 10.1542/peds.2021-053079.
7
COVID-19: Impact on prescribing and antimicrobial resistance.
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):63-68. doi: 10.37201/req/s01.19.2021. Epub 2021 Sep 30.
8
Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship.
Br J Clin Pharmacol. 2022 Mar;88(3):1143-1151. doi: 10.1111/bcp.15000. Epub 2021 Aug 17.
Zotero 插件